Vemurafenib Recruiting Phase 1 Trials for Metastatic Melanoma, BRAF V600 Mutation Positive Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs